Delivery Order SPE2DB22D1017-SPE2DB24FG5SS
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $8,001.99. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract, valued at $3,304.72, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024, with a ceiling value of $3,304.72 and a completion date of January 31, 2024. The contract is a delivery order under a firm fixed-price contract type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The award, valued at $22,504.83, was made to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 19, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,170.06 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the DLA's $999,999,999 Indefinite Delivery Contract (IDC) for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a...
This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $19,828.20, is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 19, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to support the Defense Logistics Agency's (DLA) medical supply needs. The $9,803.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024, with an ultimate completion date of November 5, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract, a Delivery Order valued at $13,233.34, has a completion date of March 7, 2024 and uses a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
The federal contract award details a delivery order for Dupixent 300 mg/2 ml syringes valued at $2,441.35. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on July 12, 2024. The contract has a firm fixed price and an ultimate completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,488.44 and an ultimate completion date of November 14, 2024. It is a Firm Fixed Price delivery order contract awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...